Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Assets Average (2016 - 2025)

Assembly Biosciences has reported Assets Average over the past 11 years, most recently at $248.8 million for Q4 2025.

  • For Q4 2025, Assets Average rose 126.76% year-over-year to $248.8 million; the TTM value through Dec 2025 reached $248.8 million, up 126.76%, while the annual FY2025 figure was $188.4 million, 47.18% up from the prior year.
  • Assets Average for Q4 2025 was $248.8 million at Assembly Biosciences, up from $160.4 million in the prior quarter.
  • Over five years, Assets Average peaked at $281.1 million in Q1 2021 and troughed at $59.1 million in Q3 2023.
  • A 5-year average of $149.7 million and a median of $123.0 million in 2024 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: crashed 55.39% in 2023 and later skyrocketed 126.76% in 2025.
  • Year by year, Assets Average stood at $220.0 million in 2021, then plummeted by 49.25% to $111.7 million in 2022, then decreased by 15.61% to $94.2 million in 2023, then grew by 16.44% to $109.7 million in 2024, then surged by 126.76% to $248.8 million in 2025.
  • Business Quant data shows Assets Average for ASMB at $248.8 million in Q4 2025, $160.4 million in Q3 2025, and $89.9 million in Q2 2025.